These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1972362

  • 41. Altered virulence and vaccination properties of Leishmania parasites grown in infected vaccinated mice.
    Gorczynski RM.
    Infect Immun; 1989 Aug; 57(8):2430-3. PubMed ID: 2744853
    [Abstract] [Full Text] [Related]

  • 42. Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.
    Mitchell GF, Handman E.
    Aust J Exp Biol Med Sci; 1983 Feb; 61(Pt 1):11-25. PubMed ID: 6870673
    [Abstract] [Full Text] [Related]

  • 43. Mechanisms of acquired immunity in leishmaniasis.
    Howard JG, Liew FY.
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov 13; 307(1131):87-98. PubMed ID: 6151691
    [Abstract] [Full Text] [Related]

  • 44. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY, Hale C, Howard JG.
    J Immunol; 1982 Apr 13; 128(4):1917-22. PubMed ID: 6120976
    [Abstract] [Full Text] [Related]

  • 45. Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection.
    Mitchell GF, Handman E, Spithill TW.
    Aust J Exp Biol Med Sci; 1984 Apr 13; 62 ( Pt 2)():145-53. PubMed ID: 6466205
    [Abstract] [Full Text] [Related]

  • 46. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M.
    J Immunol; 1986 Jul 15; 137(2):702-7. PubMed ID: 3487578
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Effects of long-term in vitro cultivation on the virulence of cloned lines of Leishmania major promastigotes.
    Segovia M, Artero JM, Mellado E, Chance ML.
    Ann Trop Med Parasitol; 1992 Aug 15; 86(4):347-54. PubMed ID: 1463354
    [Abstract] [Full Text] [Related]

  • 49. Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation.
    Rafati S, Kariminia A, Seyde-Eslami S, Narimani M, Taheri T, Lebbatard M.
    Vaccine; 2002 Jun 07; 20(19-20):2439-47. PubMed ID: 12057598
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major.
    Yang DM, Rogers MV, Liew FY.
    Immunology; 1991 Jan 07; 72(1):3-9. PubMed ID: 1997399
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.
    Yang DM, Fairweather N, Button LL, McMaster WR, Kahl LP, Liew FY.
    J Immunol; 1990 Oct 01; 145(7):2281-5. PubMed ID: 2144549
    [Abstract] [Full Text] [Related]

  • 55. Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB/c mice.
    Rostamian M, Sohrabi S, Kavosifard H, Niknam HM.
    J Microbiol Immunol Infect; 2017 Apr 01; 50(2):160-166. PubMed ID: 26066544
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
    Moll H, Mitchell GF.
    J Parasitol; 1988 Dec 01; 74(6):993-8. PubMed ID: 3264023
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.
    Howard JG, Nicklin S, Hale C, Liew FY.
    J Immunol; 1982 Nov 01; 129(5):2206-12. PubMed ID: 7119442
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.